EN PL
ORIGINAL PAPER
Combined use of third generation anti-cyclic citrullinated peptide antibodies (aCCP3 IgG/IgA), rheumatoid factors (IgM, IgG and IgA isotypes), joints magnetic resonance imaging and ultrasonography in diagnosis of juvenile idiopathic arthritis
 
More details
Hide details
 
Online publication date: 2010-07-02
 
 
Reumatologia 2010;48(3):159-164
 
KEYWORDS
ABSTRACT
Objective: The purpose of the study was to assess the utility of aCCP3 IgG and aCCP IgG/IgA (third generation anti-cyclic citrullina-ted peptide antibodies) and rheumatoid factors isotypes (IgG, IgA, IgM) in the diagnosis of undifferentiated juvenile idiopathic arthritis.
Material and methods: The following inclusion criteria were used: age < 18 years, disease onset < 16 years, inflammation of at least one joint, disease/arthritis duration > 6 weeks, other diseases have been excluded during differential diagnosis. Rheumatoid factors isotypes IgM, IgG, IgA and aCCP3 IgG and aCCP IgG/IgA have been evaluated in sera of 11 patients. Ultrasound imaging of affected joints has been done in 6 cases. MRI was carried out only in 4 most uncertain cases of patients.
Results: There were no positive results of aCCP2 IgG (> 20 IU/ml) in examined group; the mean blood level was 4.85 j/ml. There were also no positive results of aCCP3 IgG/IgA (> 20 IU/ml) in tested cohort; the mean blood level was 1.91 IU/ml. Elevated levels of RF isotypes (> 6 IU/ml) have been found in studied group. Increased level (> 6 IU/ml) of IgM RF was found in 8 patients, mean level was 20.97 IU/ml; IgA RF mean level was 22.85 IU/ml, and positive results (> 6 IU/ml) were found in 6 patients; RF IgG isotype was present in 4 patients from tested group, and mean concentration amounted to 6.48 IU/ml. In 6 cases ultrasound of affected hands\' joints was performed; erosions have been demonstrated in 2 children. MR examination was carried out in 4 most uncertain cases and erosions have been demonstrated only in 1 child.
Conclusions: 1. Third generation anti-cyclic citrullinated peptide antibodies (aCCP3 IgG/IgA) assessment &#8211; with higher specificity and sensitivity than second generation antibodies (aCCP IgG) &#8211; has no utility in JIA diagnostic algorithm. 2. MRI and ultrasound of affected joints are helpful in the diagnosis of undifferentiated JIA due to ability to confirm signs impossible to demonstrate in standard X-ray imaging.
REFERENCES (15)
1.
Korkosz M, Wojciechowski W, Kapuścińska K. i wsp. Niskopolowy rezonans magnetyczny i ultrasonografia wysokiej rozdzielczości nadgarstka, stawów śródręczno-paliczkowych i międzypaliczkowych bliższych rąk oraz przeciwciała antycytrulinowe i czynniki reumatoidalne w rozpoznawaniu wczesnego reumatoidalnego zapalenia stawów u pacjentów z niezróżnicowanym zapaleniem wielostawowym. Reumatologia 2009; 47: 51-59. .
 
2.
Ejbjerg BJ, Narvestad E, Jacobsen S, et al. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann Rheum Dis 2005; 64: 1280-1287. .
 
3.
Lindegaard HM, Vallo/ J, Ho/rslev-Petersen K, et al. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study. Ann Rheum Dis 2006; 65: 1208-1212. .
 
4.
Manger B. New developments in imaging for diagnosis and therapy monitoring in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2004; 18: 773-781. .
 
5.
Żuber Z, Piezga A, Sobczyk M i wsp. Wartość oznaczenia przeciwciał przeciwko cyklicznemu cytrulinowanemu peptydowi w diagnostyce młodzieńczego idiopatycznego zapalenia stawów. Reumatologia 2006; 44: 255-259. .
 
6.
Kasapçopur O, Altun S, Aslan M, et al. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 1687-1689. .
 
7.
Avcin T, Cimaz R, Falcini F, et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002; 61: 608-611. .
 
8.
van Rossum M, van Soesbergen R, de Kort S, et al. Anti-cyclic citrullinated peptide (anti CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 2003; 30: 825-828. .
 
9.
Hromadnikowa I, Stechova K, Pavla V, et al. Anti-cyclic cytrulinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 2002; 35: 397-401. .
 
10.
Syed RH, Gilliam BE, Moore TL. Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2008; 67: 1049-1051. .
 
11.
Walker SM, Shaham B, McCurdy DK, et al. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA. J Rheumatol 1990; 17: 936-940. .
 
12.
Walker SM, McCurdy DK, Shaham B, et al. High prevalence of IgA rheumatoid factor in severe polyarticular-onset juvenile rheumatoid arthritis, but not in systemic-onsetor pauciarticularonset disease. Arthritis Rheum 1990; 33: 199-204. .
 
13.
Saulsbury FT. Prevalence of IgM, IgA and IgG rheumatoid factors in juvenile rheumatoid arthritis. Clin Exp Rheumatol 1990, 8: 513-517. .
 
14.
Varbanova BB, Baleva M, Nikolov K, Mihailova D Prevalence of IgM-, IgA- and IgG rheumatoid factors in seronegative poly­articular disease compared to pauciarticular disease in juvenile chronic arthritis as measured by ELISA. Adv Exp Med Biol 1999; 455: 61-68. .
 
15.
Ferreira RA, Silva CH, Silva DA, et al. Is measurement of IgM and IgA rheumatoid factors (RF) in juvenile rheumatoid arthritis clinically useful? Rheumatol Int 2007; 27: 345-349.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top